Correlation Between Silo Pharma and Biovaxys Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Biovaxys Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Biovaxys Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silo Pharma and Biovaxys Technology Corp, you can compare the effects of market volatilities on Silo Pharma and Biovaxys Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Biovaxys Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Biovaxys Technology.

Diversification Opportunities for Silo Pharma and Biovaxys Technology

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Silo and Biovaxys is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Biovaxys Technology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovaxys Technology Corp and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Biovaxys Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovaxys Technology Corp has no effect on the direction of Silo Pharma i.e., Silo Pharma and Biovaxys Technology go up and down completely randomly.

Pair Corralation between Silo Pharma and Biovaxys Technology

Given the investment horizon of 90 days Silo Pharma is expected to under-perform the Biovaxys Technology. But the otc stock apears to be less risky and, when comparing its historical volatility, Silo Pharma is 1.3 times less risky than Biovaxys Technology. The otc stock trades about -0.01 of its potential returns per unit of risk. The Biovaxys Technology Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  4.62  in Biovaxys Technology Corp on September 2, 2024 and sell it today you would earn a total of  0.41  from holding Biovaxys Technology Corp or generate 8.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Silo Pharma  vs.  Biovaxys Technology Corp

 Performance 
       Timeline  
Silo Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Silo Pharma is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Biovaxys Technology Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Biovaxys Technology Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting basic indicators, Biovaxys Technology reported solid returns over the last few months and may actually be approaching a breakup point.

Silo Pharma and Biovaxys Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Silo Pharma and Biovaxys Technology

The main advantage of trading using opposite Silo Pharma and Biovaxys Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Biovaxys Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovaxys Technology will offset losses from the drop in Biovaxys Technology's long position.
The idea behind Silo Pharma and Biovaxys Technology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments